Why Blood Cancer?

Since 2000, more than 40% of cancer-fighting therapies approved by the FDA were first approved to treat blood cancer patients and many of these therapies are now helping patients with non-blood cancers. Some of the approved therapies are chemotherapy, bone and stem cell transplantation, and more recently immunotherapy.

Blood Cancer Statistics

An estimated 184,720 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2023. Within the last ten years, blood cancer survival rates have doubled, tripled, or quadrupled depending on the specific cancer. An estimated 1,629,474 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.

Climb

Event Day: Sunday March 24, 2024

General Registration: OPEN NOW

There is a fundraising minimum of $150/person ($100/person for those 17 and under) to benefit the Leukemia & Lymphoma Society's mission to eradicate blood cancers. Please note: All participants must reach the fundraising minimum to climb on event day.

Volunteer

If you are interested in volunteering for the event, please click below, or reach out to our Campaign Development Manager, Alison Ogliore, at alison.ogliore@lls.org or 206.957.4560 with any questions.